Cipla Limited is a publicly traded company listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) of India. As of December 31, 2022, the promoter group, led by Yusuf K. Hamied and his family, held approximately 33.61% of the company's equity shares. The remaining shares are held by institutional investors, mutual funds, and individual shareholders.

Yes, Cipla is considered a reputable company in the pharmaceutical industry. In Q3 FY25, Cipla reported a 49% increase in net profit, driven by strong domestic demand for respiratory and urology treatments, despite a slight decline in U.S. sales. The company has a longstanding commitment to providing affordable medicines globally and has been recognized for its contributions to public health.

Yes, Cipla is a multinational pharmaceutical company headquartered in Mumbai, India. It operates in over 80 countries and has 34 manufacturing units across India. Cipla's global presence includes subsidiaries such as Invagen Pharmaceuticals in the U.S. and Cipla Medpro in South Africa.

As of recent industry reports, Cipla is ranked among the top 5 pharmaceutical companies in India by market capitalization and domestic sales. It consistently competes with other major players like Sun Pharma, Dr. Reddy’s, and Lupin in terms of prescription volumes and revenue.

The full form of CIPLA is Chemical, Industrial & Pharmaceutical Laboratories. It was founded in 1935 by Dr. Khwaja Abdul Hamied in Mumbai, India.

You can buy Axis Bank shares using Navia App. Open a Free Demat account and add the scrip in the watchlist. Select buy and enter the bid quantity to buy the stock.

The share price of any stocks is volatile and keeps changing throughout the day owing to different factors. Axis Bank Industries share price is “₹” as of “.”

XXX today high is and today low of is